The effect of Nimudipine on LH

Effect of Nimes Dopamine on prevention of early onset of LH in patients under IUI

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141223020408N6

Enrollment

Registered

2018-08-12

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INFERTILITI. Female infertility associated with anovulation

Interventions

Intervention group: People who received Nimrodipine.

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women aged 20 to 40 years Having both healthy ovaries in biographies and ultrasound assessment Having at least one open tube in hysterosalpingography ????? ???????? ? ?????? ??? ?????? IUI ???? ???? ????? 59/5000Diagnosis of infertility and the choice of IUI treatment by a physician

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Prevention if LH surge. Timepoint: Before the intervention and the time of observation, at least two 18 mm follicles in ultrasound. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact???? ???????

Shahid Beheshti University of Medical Sciences

z.razghandi@gmail.com+98 21 2271 8005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026